Drug purchases under the 340B program totaled $53.7 billion in 2022, or 22.3% more than the $43.9 billion in 2021, [...] …
Month: September 2023
Hospital 340B covered entity and child sites increased by more than 400% over the last 11 years, while the number [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program could more than double in size if the 340B patient definition expands, according to a recent report [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Senate committee rejected an effort to add new 340B hospital verification requirements as part of a sweeping healthcare funding [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Attorneys representing Arkansas and 340B providers sparred with a drug industry lawyer over the constitutionality of Arkansas’ first-in-the-nation 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Teva Pharmaceuticals this week ended its 340B contract pharmacy restrictions in Arkansas in response to a state law that prevents [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Located in rural Peterborough, New Hampshire, Monadnock Community Hospital (MCH) is a critical access hospital that offers comprehensive inpatient and outpatient services and is celebrating its 100th anniversary. MCH joined a Signify Health Accountable Care Organization (ACO) in 2023 to align with the Centers for Medicare & Medicaid Services’ goal of having all Medicare beneficiaries in an accountable care relationship by 2030. Like many of their rural-based peers, they have transitioned from fee-for-service healthcare to value-based care using Signify’s proven population health methodologies and award-winning technology to improve patient care outcomes.
Rural-based providers face particular sets of obstacles that can make healthcare delivery challenging. Rural communities often have limited access to resources, technology, and specialists, while many of the patients in these areas experience concomitant chronic illnesses. This makes for a perfect storm of limited supply with high demand.
For more than 30 years, the 340B program has provided financial assistance to
…
Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Nearly one-quarter of the 200 provider audits planned for this year were closed by regulators with no adverse findings, they [...] …